妊娠糖尿病母亲初乳中内分泌激素的水平及其与婴儿早期生长的关系-现代医学

妊娠糖尿病母亲初乳中内分泌激素的水平及其与婴儿早期生长的关系

单位：南京医科大学/常州市妇幼保健院/常州医学中心新生儿科, 江苏常州 213000

分类号：R714.256

出版年·卷·期（页码）：2022·50·第七期（822-828）

摘要：

目的：探讨妊娠期糖尿病（gestational diabetes mellitus，GDM）产妇初乳中内分泌相关激素与婴儿早期体质量增长的关系。方法：收集常州市妇幼保健院2019年7月至2020年6月单胎足月分娩GDM产妇和母乳喂养健康婴儿（GDM组）以及单胎足月分娩孕期无并发症产妇和母乳喂养健康婴儿（对照组）出生、1、3、6月龄时的临床资料。采用随机方法收集两组初乳，检测脂联素、胰岛素、瘦素、抵抗素、肝细胞生长因子（HGF）、表皮生长因子（EGF）和血管内皮生长因子（VEGF）水平。结果：两组各纳入250例，对照组剖宫产比例、婴儿出生体质量及体质量Z评分分别是94/250（18.80%）、（3.35±0.36）kg、（0.14±0.79）分，GDM组为116/250（23.20%）、（3.43±0.39）kg、（0.29±0.79）分，差异均有统计学意义（P<0.05）。两组1、3、6月龄体质量及Z评分无差异（P>0.05）。GDM组初乳中HGF含量为3.88（1.79~4.39）ng·ml^-1，显著高于对照组的1.64（0.52~3.66）ng·ml^-1（P<0.05），其它均无差异（P>0.05）。结论：虽然GDM组婴儿出生体质量及Z评分明显高于对照组，但在母乳喂养条件下GDM组婴儿早期特别是新生儿期的体质量与非GDM组婴儿没有差异。母乳喂养对GDM产妇婴儿早期体质量增长有益，可避免婴儿早期肥胖的发生，且可能与初乳HGF水平明显升高有关，这有待更进一步的研究。

Objective: To investigate the hormones levels in colostrum of mothers with gestational diabetes mellitus(GDM) and its relationship with early-life weight gain of infants. Methods: The singleton full-term delivery of GDM maternal and breastfeeding infants(GDM group) in Changzhou Maternal and Child Health Hospital from July 2019 to June 2020 was enrolled. At the same time, the maternal and singleton full-term delivery with the same gestational age and without pregnancy complications were selected as the control group. Maternal perinatal information and weight of the infants were regularly measured at birth, 1, 3 and 6 months old and the Z score of the weight were calculated to evaluate the development level of all the infants. And the colostrum of the two groups was collected randomly. The levels of adiponectin, insulin, leptin, resistin, hepatocyte growth factor(HGF), epidermal growth factor(EGF) and vascular endothelial cell growth factor(VEGF) in colostrum were detected by enzyme linked immunosorbent assay(ELISA) or chemiluminescence analysis. Results: A total of 500 breast-fed infants were included, including 250 in control group and 250 in GDM group. In the control group, cesarean section rate, birth weight, birth weight Z score of infants were 94/250(18.80%), (3.35±0.36)kg, (0.14±0.79), respectively, while those in the GDM group were 116/250(23.20%), (3.43±0.39)kg, (0.29±0.79), respectively. There were statistically significant differences in cesarean delivery ratio, birth weight, birth weight Z score(P<0.05) except for maternal age. And there were no significant differences in infants' weight and Z score of weight at age of 1, 3, 6 months old between the two groups(P>0.05). The content of HGF in colostrum of the control group[n=38, 1.64(0.52-3.66)ng·ml^-1] was significantly lower than that of the GDM group[n=27, 3.88(1.79-4.39) ng·ml^-1](P<0.05), while there was no significant difference in adiponectin, insulin, leptin, resistin, EGF and VEGF(P>0.05). Conclusion: The birth weight and Z score of infants in the GDM group are significantly higher than those in the control group. However, there is no difference in the weight and Z score of infants with breastfeeding in the early infancy, especially neonatal period of the two groups. Breastfeeding is beneficial to the early infant weight gain with GDM mothers, which may avoid early infant obesity. And it may be related to the significantly increase of HGF in colostrum, which needs further study.

参考文献：

[1] JOHNS E C, DENISON F C, NORMAN J E, et al.Gestational diabetes mellitus:mechanisms, treatment, and complications[J].Trends Endocrinol Metab, 2018, 29(11):743-754.
[2] GAO C, SUN X, LU L, et al.Prevalence of gestational diabetes mellitus in mainland China:a systematic review and meta-analysis[J].J Diabetes Investig, 2019, 10(1):154-162.
[3] YAN J, LIU L, ZHU Y, et al.The association between breastfeeding and childhood obesity:a meta-analysis[J].BMC Public Health, 2014, 14:1267.
[4] GUNDERSON E P, HURSTON S R, DEWEY K G, et al.The study of women, infant feeding and type 2 diabetes after GDM pregnancy and growth of their offspring(SWIFT Offspring study):prospective design, methodology and baseline characteristics[J].BMC Pregnancy Childbirth, 2015, 15:150.
[5] HARDER T, BERGMANN R, KALLISCHNIGG G, et al.Duration of breastfeeding and risk of overweight:a meta-analysis[J].Am J Epidemiol, 2005, 162(5):397-403.
[6] WHITAKER K M, MARINO R C, HAAPALA J L, et al.Associations of maternal weight status before, during, and after pregnancy with inflammatory markers in breast milk[J].Obesity(Silver Spring), 2018, 26(10):1659-1660.
[7] SADR D G, WHITAKER K M, HAAPALA J L, et al.Relationship of maternal weight status before, during, and after pregnancy with breast milk hormone concentrations[J].Obesity(Silver Spring), 2019, 27(4):621-628.
[8] CHOI Y, NAGEL E M, KHAROUD H, et al.Gestational diabetes mellitus is associated with differences in human milk hormone and cytokine concentrations in a fully breastfeeding united states cohort[J].Nutrients, 2022, 14(3):667.
[9] ANDREAS N J, HYDE M J, GALE C, et al.Effect of maternal body mass index on hormones in breast milk:a systematic review[J].PLoS One, 2014, 9(12):e115043.
[10] MUNBLIT D, TRENEVA M, PERONI D G, et al.Colostrum and mature human milk of women from London, Moscow, and Verona:determinants of immune composition[J].Nutrients, 2016, 8(11):695.
[11] KHODABAKHSHI A, MEHRAD-MAJD H, VAHID F, et al.Association of maternal breast milk and serum levels of macronutrients, hormones, and maternal body composition with infant's body weight[J].Eur J Clin Nutr, 2018, 72(3):394-400.
[12] KHODABAKHSHI A, GHAYOUR-MOBARHAN M, ROOKI H, et al.Comparative measurement of ghrelin, leptin, adiponectin, EGF and IGF-1 in breast milk of mothers with overweight/obese and normal-weight infants[J].Eur J Clin Nutr, 2015, 69(5):614-618.
[13] LOUI A, EILERS E, STRAUSS E, et al.Vascular endothelial growth factor(VEGF) and soluble VEGF receptor 1(sFlt-1) levels in early and mature human milk from mothers of preterm versus term infants[J].J Hum Lact, 2012, 28(4):522-528.
[14] YU X, RONG S S, SUN X, et al.Associations of breast milk adiponectin, leptin, insulin and ghrelin with maternal characteristics and early infant growth:a longitudinal study[J].Br J Nutr, 2018, 120(12):1380-1387.
[15] 许继志, 刘华, 陈铁强.糖尿病母亲分娩的足月小于胎龄儿外周血胰岛素样生长因子2/H19甲基化和mRNA的表达[J].中华实用儿科临床杂志, 2019(7):517-520.
[16] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017版)[J].中国实用内科杂志, 2018, 38(4):292-344.
[17] SZMUILOWICZ E D, JOSEFSON J L, METZGER B E.Gestational diabetes mellitus[J].Endocrin Metab Clin, 2019, 48(3):479-493.
[18] KC K, SHAKYA S, ZHANG H.Gestational diabetes mellitus and macrosomia:a literature review[J].Ann Nutr Metab, 2015, 66(Suppl 2):14-20.
[19] ARIS I M, SOH S E, TINT M T, et al.Associations of infant milk feed type on early postnatal growth of offspring exposed and unexposed to gestational diabetes in utero[J].Eur J Nutr, 2017, 56(1):55-64.
[20] GOU B H, GUAN H M, BI Y X, et al.Gestational diabetes:weight gain during pregnancy and its relationship to pregnancy outcomes[J].Chin Med J(Engl), 2019, 132(2):154-160.
[21] ALEJANDRO E U, MAMERTO T P, CHUNG G, et al.Gestational diabetes mellitus:a harbinger of the vicious cycle of diabetes[J].Int J Mol Sci, 2020, 21(14):5003.
[22] LIND M V, LARNKJAER A, MOLGAARD C, et al.Breastfeeding, breast milk composition, and growth outcomes[J].Nestle Nutr Inst Workshop Ser, 2018, 89:63-77.
[23] SHAMIR R.The benefits of breast feeding[J].Nestle Nutr Inst Workshop Ser, 2016, 86:67-76.
[24] DUGAS C, PERRON J, KEARNEY M, et al.Postnatal prevention of childhood obesity in offspring prenatally exposed to gestational diabetes mellitus:where are we now?[J].Obes Facts, 2017, 10(4):396-406.
[25] GUNDERSON E P, HURSTON S R, DEWEY K G, et al.The study of women, infant feeding and type 2 diabetes after GDM pregnancy and growth of their offspring(SWIFT Offspring study):prospective design, methodology and baseline characteristics[J].BMC Pregnancy Childbirth, 2015, 15:150.
[26] NOURELDEEN A F, QUSTI S Y, AL-SEENI M N, et al.Maternal leptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes[J].Indian J Clin Biochem, 2014, 29(4):462-470.
[27] GRISSA O, YESSOUFOU A, MRISAK I, et al.Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus:possible interactions with macrosomia[J].BMC Pregnancy Childbirth, 2010, 10:7.
[28] KELESIDIS T, KELESIDIS I, CHOU S, et al.Narrative review:the role of leptin in human physiology:emerging clinical applications[J].Ann Intern Med, 2010, 152(2):93-100.
[29] FANG H, JUDD R L.Adiponectin regulation and function[J].Compr Physiol, 2018, 8(3):1031-1063.
[30] NUNES M, DA S C, BOSA V L, et al.Could a remarkable decrease in leptin and insulin levels from colostrum to mature milk contribute to early growth catch-up of SGA infants?[J].BMC Pregnancy Childbirth, 2017, 17(1):410.
[31] LEY S H, HANLEY A J, SERMER M, et al.Associations of prenatal metabolic abnormalities with insulin and adiponectin concentrations in human milk[J].Am J Clin Nutr, 2012, 95(4):867-874.
[32] CHAN D, GORUK S, BECKER A B, et al.Adiponectin, leptin and insulin in breast milk:associations with maternal characteristics and infant body composition in the first year of life[J].Int J Obes(Lond), 2018, 42(1):36-43.
[33] XU J, ZHAO Y H, CHEN Y P, et al.Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus:a systematic review and meta-analysis[J].Sci World J, 2014, 2014:926932.
[34] YOUNG B E, PATINKIN Z, PALMER C, et al.Human milk insulin is related to maternal plasma insulin and BMI:but other components of human milk do not differ by BMI[J].Eur J Clin Nutr, 2017, 71(9):1094-1100.
[35] MANK E, VAN T L, HEIJBOER A C, et al.Insulin concentration in human milk in the first ten days postpartum:course and associated factors[J].J Pediatr Gastroenterol Nutr, 2021, 73(5):e115-e119.
[36] ONCUL M, TUTEN A, ERMAN H, et al.Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus[J].Minerva Med, 2013, 104(5):527-535.
[37] SAVINO F, SORRENTI M, BENETTI S, et al.Resistin and leptin in breast milk and infants in early life[J].Early Hum Dev, 2012, 88(10):779-782.
[38] SIAFAKAS C G, ANATOLITOU F, FUSUNYAN R D, et al.Vascular endothelial growth factor(VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells[J].Pediatr Res, 1999, 45(5 Pt 1):652-657.
[39] KRISHNASAMY S, RAVI V, RAJARAMAN B, et al.Role of VEGF165b/VEGFTOTAL ratio in gestational diabetes mellitus[J].Gynecol Endocrinol, 2019, 35(9):811-814.
[40] LU M, JIANG J, WU K, et al.Epidermal growth factor and transforming growth factor-alpha in human milk of different lactation stages and different regions and their relationship with maternal diet[J].Food Funct, 2018, 9(2):1199-1204.
[41] KNOOP K A, COUGHLIN P E, FLOYD A N, et al.Maternal activation of the EGFR prevents translocation of gut-residing pathogenic Escherichia coli in a model of late-onset neonatal sepsis[J].Proc Natl Acad Sci U S A, 2020, 117(14):7941-7949.
[42] DE M T, CONGET P, BECERRA-BAYONA S, et al.The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice[J].PLoS One, 2017, 12(6):e177533.
[43] MOOSAVI F, GIOVANNETTI E, SASO L, et al.HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers[J].Crit Rev Clin Lab Sci, 2019, 56(8):533-566.
[44] OLIVEIRA A G, ARAUJO T G, CARVALHO B M, et al.The role of hepatocyte growth factor(HGF) in insulin resistance and diabetes[J].Front Endocrinol(Lausanne), 2018, 9:503.
[45] YAMADA Y, SAITO S, MORIKAWA H.Hepatocyte growth factor in human breast milk[J].Am J Reprod Immunol, 1998, 40(2):112-120.
[46] KOBATA R, TSUKAHARA H, OHSHIMA Y, et al.High levels of growth factors in human breast milk[J].Early Hum Dev, 2008, 84(1):67-69.
[47] MURATSU J, IWABAYASHI M, SANADA F, et al.Hepatocyte growth factor prevented high-fat diet-induced obesity and improved insulin resistance in mice[J].Sci Rep, 2017, 7(1):130.
[48] LI B, LEUNG J, CHAN L, et al.Amelioration of endoplasmic reticulum stress by mesenchymal stem cells via hepatocyte growth factor/c-Met signaling in obesity-associated kidney injury[J].Stem Cells Transl Med, 2019, 8(9):898-910.
[49] KAINGADE P M, SOMASUNDARAM I, NIKAM A B, et al.Assessment of growth factors secreted by human breastmilk mesenchymal stem cells[J].Breastfeed Med, 2016, 11(1):26-31.
[50] MENG S S, GUO F M, ZHANG X W, et al.mTOR/STAT-3 pathway mediates mesenchymal stem cell-secreted hepatocyte growth factor protective effects against lipopolysaccharide-induced vascular endothelial barrier dysfunction and apoptosis[J].J Cell Biochem, 2019, 120(3):3637-3650.
[51] WANG M, SONG L, STRANGE C, et al.Therapeutic effects of adipose stem cells from diabetic mice for the treatment of type 2 diabetes[J].Mol Ther, 2018, 26(8):1921-1930.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录